Lishengpharma(SZ:002393) Sou Hu Cai Jing·2025-11-04 08:57Core Viewpoint - The Tianjin state-owned enterprise reform sector experienced a slight decline of 0.13% on November 4, with Lisheng Pharmaceutical leading the losses. The Shanghai Composite Index closed at 3960.19, down 0.41%, while the Shenzhen Component Index closed at 13175.22, down 1.71% [1][2]. Stock Performance Summary - The following stocks in the Tianjin state-owned enterprise reform sector showed varying performance: - Tianjin Bin Development (Code: 000897) closed at 2.39, up 1.70% with a trading volume of 581,600 shares and a turnover of 139 million yuan [1]. - Tianjin Investment City Development (Code: 600322) closed at 2.61, up 1.56% with a trading volume of 359,200 shares and a turnover of 93.08 million yuan [1]. - Lisheng Pharmaceutical (Code: 002393) closed at 21.39, down 1.66% with a trading volume of 33,000 shares and a turnover of 70.82 million yuan [2]. - Bohai Chemical (Code: 600800) closed at 4.08, down 0.24% with a trading volume of 228,500 shares and a turnover of 93.09 million yuan [2]. Capital Flow Analysis - On the same day, the Tianjin state-owned enterprise reform sector saw a net outflow of 114 million yuan from institutional investors, while retail investors contributed a net inflow of 138 million yuan [2][3]. - The capital flow for specific stocks indicated: - Lisheng Pharmaceutical experienced a significant net outflow of 11.29 million yuan from institutional investors, with a retail net inflow of 7.32 million yuan [3]. - Tianjin Port (Code: 600717) had a net outflow of 11.99 million yuan from institutional investors, while retail investors contributed a net inflow of 10.89 million yuan [3].